Adient (ADNT) shares dipped under 1% today to $23.43, slightly underperforming the broader auto parts sector. Despite the minor pullback on Thursday, the stock has rallied over 25% this month.
This surge follows a major analyst upgrade and a wave of positive sentiment across Wall Street regarding the company’s valuation and revenue projections.
| Current Price | $23.43 |
| Daily Change | -0.72% 🔴 |
| Day Range | $23.04 – $23.70 |
| 52-Week Range | $10.04 – $26.16 |
On January 14, UBS upgraded the stock from Neutral to Buy, providing a significant catalyst for recent price action.
This momentum marks a notable recovery for the cyclical automotive seating manufacturer, which had previously experienced an almost 9% decline over the preceding month.
The stock's recent performance is highlighted by high volatility, with a Beta of 1.76. While today's movement was negative, the 1-year change remains positive, with shares up nearly 35% over the last 12 months.
| Time Period | Price Change | Performance |
|---|---|---|
| 1 Month | +25.27% | 🟢 |
| 3 Months | +1.25% | 🟢 |
| 6 Months | +6.58% | 🟢 |
| 1 Year | +34.75% | 🟢 |
Key Takeaways
- ADNT fell roughly 0.7% today but is up more than 25% over the last 30 days.
- UBS upgraded the stock to Buy with a price target of $26.67, suggesting further upside.
- Wells Fargo raised its price target to $29.00 while maintaining an Overweight rating.
- Adient trades at a price-to-sales ratio of 0.28, significantly lower than the industry average of 0.54.
- The company will report its first quarter fiscal 2026 financial results on February 4.
What's Driving Adient's (ADNT) Recent Stock Movement?
The primary driver behind Adient’s recent climb is a shift in analyst sentiment. On January 14, 2026, UBS moved its rating from Neutral to Buy, citing strong growth prospects.
Market data indicates that while the stock saw a slight retreat today, its monthly performance has been bolstered by significant institutional interest and a shift in market sentiment following late 2025 lows.
Additionally, the company confirmed via a press release on January 13 that it will host its next earnings call on February 4.
This announcement has provided investors with a clear timeline for the next major financial update. The stock's current price of $23.43 sits comfortably within its 52-week range of $10.04 to $26.16.
What Did UBS's Upgrade Mean for ADNT Stock?
The UBS upgrade was supported by robust financial projections for the coming year. Analysts at the firm projected annual revenue for Adient to reach $16,766 million, which would represent an increase of more than 15%.
Furthermore, UBS estimated a non-GAAP EPS of $8.70 for the company.
The average one-year price target set by UBS is $26.67, implying an upside of nearly 13% from the recent closing price of $23.61. Institutional data also shows a bullish outlook, with a put/call ratio of 0.16.
While the total number of institutional shares decreased by roughly 4.5% last quarter, the average portfolio weight allocated to ADNT by funds increased by more than 21%.
How Do Analysts View Adient's Future Performance?
Beyond UBS, other major firms are showing increased confidence in Adient's trajectory. Wells Fargo analyst Colin Langan recently raised the firm’s price target from $28.00 to $29.00, a hike of about 3.5%.
Wells Fargo continues to maintain an Overweight rating on the stock. According to data from GuruFocus, the average price target from 11 analysts is $26.15.
This target range is wide, extending from a low of $20.20 to a high of $54.72. Monitoring analyst consensus and price targets is a key part of successful stock investing.
In fiscal 2025, Adient reported consolidated revenue of $14.5 billion, supplemented by $3.5 billion from unconsolidated joint ventures.
Is Insider Activity Signaling Confidence in Adient?
Recent SEC filings reveal standard equity-based compensation for Adient's leadership. On January 1, 2026, CEO Jerome J. Dorlack was granted 14,866 restricted stock units (RSUs) at a price of $0.
These units are scheduled to vest on the one-year anniversary of the grant. During the same period, 5,234 ordinary shares were withheld at a price of $19.17 per share to cover tax obligations.
Following these transactions, Dorlack directly owns 636,182 ordinary shares. While these transactions are standard executive compensation, they maintain the CEO's significant direct stake in the company’s performance.
| 🟢 Bull Case | 🔴 Bear Case |
|---|---|
| • UBS/Wells Fargo price targets ($26.67 – $29.00) | • Institutional shares decreased by 4.46% |
| • Undervalued P/S of 0.28 vs 0.54 industry avg | • High stock volatility (Beta: 1.76) |
| • Projected non-GAAP EPS of $8.70 (UBS) | • Warnings of lower customer production volumes |
How Does Adient Compare to Its Auto Parts Peers?
Despite its monthly gains, Adient underperformed its peers during today's session. The broader auto parts industry saw an average gain of 0.9%, while ADNT dropped 0.7%.
In comparison, peers like Monro, Inc. (MNRO) rose nearly 2.7%, and Dorman Products (DORM) climbed over 2.2%.
| Company | Symbol | Daily Change | Market Cap |
|---|---|---|---|
| Monro, Inc. | MNRO | +2.69% 🟢 | N/A |
| Dorman Products, Inc. | DORM | +2.28% 🟢 | N/A |
| BorgWarner Inc. | BWA | +0.98% 🟢 | N/A |
| Industry Avg | – | +0.91% | – |
| Adient plc | ADNT | -0.72% 🔴 | N/A |
Adient remains attractively valued compared to the wider market on a price-to-sales (P/S) basis. While investors often look at a stock's P/E ratio, Adient's P/S ratio of 0.28 is significantly lower than the industry average of 0.54.
This valuation gap is a key point of interest for value-oriented investors who follow the automotive seating sector. The S&P 500's ratio sits much higher at 3.82.
What Should ADNT Investors Watch Next?
The next major milestone for investors is the Q1 fiscal 2026 earnings report, scheduled for February 4, 2026, at 8:30 a.m. ET. Markets will look for updates on adjusted EBITDA, which reached $226 million in late 2025.
Investors should also weigh management's previous warnings regarding production volumes. The company noted that lower customer production volumes and growth investments could offset some performance gains in fiscal 2026.
With a high beta and a recent history of price swings, the stock is likely to remain sensitive to vehicle production data.
The Bottom Line
Adient’s recent performance reflects a stock in transition, catching the attention of major analysts through its low valuation and projected revenue growth. While the stock faced a minor setback today, the 25% monthly rally suggests a shift in market sentiment.
However, the path forward remains complex. High volatility and management's own forecasts regarding customer production volumes suggest that the stock may face headwinds.
Investors will likely look to the February earnings call for confirmation that the company's financial performance can sustain its recent momentum.
